Showing results (151-160 of 1,656) with videos related to

Sort By:
Pageof 166
Chemosphere|May 6, 2017
Impacts of Rac- and S-metolachlor on cyanobacterial cell integrity and release of microcystins at different nitrogen levelsJia Wang, Lijuan Zhang, Jiajia Fan, et al.
Environmental Geochemistry and Health|April 11, 2018
Toxicity assessment of copper by electrochemically active bacteria in wastewaterLijuan Zhang, Sam Fong Yau Li, Huchun Tao
The Journal of Physical Chemistry. A|January 9, 2010
Structures and spectroscopic properties of fluoroboron-subtriazaporphyrin derivatives: density functional theory approach on the benzo-fusing effectDongdong Qi, Yuexing Zhang, Lijuan Zhang, et al.
Analytical Chemistry|September 30, 2008
Mass spectrometry analysis of phosphopeptides after peptide carboxy group derivatizationYawei Xu, Lijuan Zhang, Haojie Lu, et al.
International Journal of Clinical and Experimental Pathology|March 11, 2015
RNA interference targeting enhancer of polycomb1 exerts anti-tumor effects in lung cancerChunli Che, Lijuan Zhang, Jianmin Huo, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 14, 2023
Phytochemicals targeting lncRNAs: A novel direction for neuroprotection in neurological disordersHang Zhao, Lin Wang, Lijuan Zhang, et al.
Oncology Reports|January 22, 2019
MicroRNA‑3653 inhibits the growth and metastasis of hepatocellular carcinoma by inhibiting ITGB1Lijuan Zhang, Tao Zhang, Zerun Deng, et al.
Frontiers in Nutrition|June 30, 2025
Altered mitochondrial function: a clue therapeutic strategies between metabolic dysfunction-associated steatotic liver disease and chronic kidney disease?Jiang Bai, Lijuan Zhang, Letian He, et al.
World Journal of Surgical Oncology|May 16, 2025
The association of immune-inflammation indices at multiple time points with treatment response and survival in advanced non-small cell lung cancer patients receiving immune checkpoint inhibitorsYaqing Li, Jianping Xu, Lijuan Zhang, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 3, 2019
Tivantinib Hampers the Proliferation of Glioblastoma Cells via PI3K/Akt/Mammalian Target of Rapamycin (mTOR) SignalingYukun Wu, Zhizhang Li, Lijuan Zhang, et al.
Pageof 166